Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
29049554
TITLE
Genetic Association of Major Depression With Atypical Features and Obesity-Related Immunometabolic Dysregulations.
ABSTRACT
Importance
The association between major depressive disorder (MDD) and obesity may stem from shared immunometabolic mechanisms particularly evident in MDD with atypical features, characterized by increased appetite and/or weight (A/W) during an active episode.
Objective
The association between major depressive disorder (MDD) and obesity may stem from shared immunometabolic mechanisms particularly evident in MDD with atypical features, characterized by increased appetite and/or weight (A/W) during an active episode. To determine whether subgroups of patients with MDD stratified according to the A/W criterion had a different degree of genetic overlap with obesity-related traits (body mass index [BMI] and levels of C-reactive protein [CRP] and leptin).
Design, Setting, and Patients
The association between major depressive disorder (MDD) and obesity may stem from shared immunometabolic mechanisms particularly evident in MDD with atypical features, characterized by increased appetite and/or weight (A/W) during an active episode. To determine whether subgroups of patients with MDD stratified according to the A/W criterion had a different degree of genetic overlap with obesity-related traits (body mass index [BMI] and levels of C-reactive protein [CRP] and leptin). This multicenter study assembled genome-wide genotypic and phenotypic measures from 14 data sets of the Psychiatric Genomics Consortium. Data sets were drawn from case-control, cohort, and population-based studies, including 26 628 participants with established psychiatric diagnoses and genome-wide genotype data. Data on BMI were available for 15 237 participants. Data were retrieved and analyzed from September 28, 2015, through May 20, 2017.
Main Outcomes and Measures
The association between major depressive disorder (MDD) and obesity may stem from shared immunometabolic mechanisms particularly evident in MDD with atypical features, characterized by increased appetite and/or weight (A/W) during an active episode. To determine whether subgroups of patients with MDD stratified according to the A/W criterion had a different degree of genetic overlap with obesity-related traits (body mass index [BMI] and levels of C-reactive protein [CRP] and leptin). This multicenter study assembled genome-wide genotypic and phenotypic measures from 14 data sets of the Psychiatric Genomics Consortium. Data sets were drawn from case-control, cohort, and population-based studies, including 26 628 participants with established psychiatric diagnoses and genome-wide genotype data. Data on BMI were available for 15 237 participants. Data were retrieved and analyzed from September 28, 2015, through May 20, 2017. Lifetime DSM-IV MDD was diagnosed using structured diagnostic instruments. Patients with MDD were stratified into subgroups according to change in the DSM-IV A/W symptoms as decreased or increased.
Results
The association between major depressive disorder (MDD) and obesity may stem from shared immunometabolic mechanisms particularly evident in MDD with atypical features, characterized by increased appetite and/or weight (A/W) during an active episode. To determine whether subgroups of patients with MDD stratified according to the A/W criterion had a different degree of genetic overlap with obesity-related traits (body mass index [BMI] and levels of C-reactive protein [CRP] and leptin). This multicenter study assembled genome-wide genotypic and phenotypic measures from 14 data sets of the Psychiatric Genomics Consortium. Data sets were drawn from case-control, cohort, and population-based studies, including 26 628 participants with established psychiatric diagnoses and genome-wide genotype data. Data on BMI were available for 15 237 participants. Data were retrieved and analyzed from September 28, 2015, through May 20, 2017. Lifetime DSM-IV MDD was diagnosed using structured diagnostic instruments. Patients with MDD were stratified into subgroups according to change in the DSM-IV A/W symptoms as decreased or increased. Data included 11 837 participants with MDD and 14 791 control individuals, for a total of 26 628 participants (59.1% female and 40.9% male). Among participants with MDD, 5347 (45.2%) were classified in the decreased A/W and 1871 (15.8%) in the increased A/W subgroups. Common genetic variants explained approximately 10% of the heritability in the 2 subgroups. The increased A/W subgroup showed a strong and positive genetic correlation (SE) with BMI (0.53 [0.15]; P = 6.3 × 10-4), whereas the decreased A/W subgroup showed an inverse correlation (-0.28 [0.14]; P = .06). Furthermore, the decreased A/W subgroup had a higher polygenic risk for increased BMI (odds ratio [OR], 1.18; 95% CI, 1.12-1.25; P = 1.6 × 10-10) and levels of CRP (OR, 1.08; 95% CI, 1.02-1.13; P = 7.3 × 10-3) and leptin (OR, 1.09; 95% CI, 1.06-1.12; P = 1.7 × 10-3).
Conclusions and Relevance
The association between major depressive disorder (MDD) and obesity may stem from shared immunometabolic mechanisms particularly evident in MDD with atypical features, characterized by increased appetite and/or weight (A/W) during an active episode. To determine whether subgroups of patients with MDD stratified according to the A/W criterion had a different degree of genetic overlap with obesity-related traits (body mass index [BMI] and levels of C-reactive protein [CRP] and leptin). This multicenter study assembled genome-wide genotypic and phenotypic measures from 14 data sets of the Psychiatric Genomics Consortium. Data sets were drawn from case-control, cohort, and population-based studies, including 26 628 participants with established psychiatric diagnoses and genome-wide genotype data. Data on BMI were available for 15 237 participants. Data were retrieved and analyzed from September 28, 2015, through May 20, 2017. Lifetime DSM-IV MDD was diagnosed using structured diagnostic instruments. Patients with MDD were stratified into subgroups according to change in the DSM-IV A/W symptoms as decreased or increased. Data included 11 837 participants with MDD and 14 791 control individuals, for a total of 26 628 participants (59.1% female and 40.9% male). Among participants with MDD, 5347 (45.2%) were classified in the decreased A/W and 1871 (15.8%) in the increased A/W subgroups. Common genetic variants explained approximately 10% of the heritability in the 2 subgroups. The increased A/W subgroup showed a strong and positive genetic correlation (SE) with BMI (0.53 [0.15]; P = 6.3 × 10-4), whereas the decreased A/W subgroup showed an inverse correlation (-0.28 [0.14]; P = .06). Furthermore, the decreased A/W subgroup had a higher polygenic risk for increased BMI (odds ratio [OR], 1.18; 95% CI, 1.12-1.25; P = 1.6 × 10-10) and levels of CRP (OR, 1.08; 95% CI, 1.02-1.13; P = 7.3 × 10-3) and leptin (OR, 1.09; 95% CI, 1.06-1.12; P = 1.7 × 10-3). The phenotypic associations between atypical depressive symptoms and obesity-related traits may arise from shared pathophysiologic mechanisms in patients with MDD. Development of treatments effectively targeting immunometabolic dysregulations may benefit patients with depression and obesity, both syndromes with important disability.
DATE PUBLISHED
2017 12 01
HISTORY
PUBSTATUS PUBSTATUSDATE
pubmed 2017/10/20 06:00
medline 2017/12/14 06:00
entrez 2017/10/20 06:00
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Milaneschi Y Milaneschi Yuri Y Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Vrije Universiteit Medical Center and GGZ inGeest, Amsterdam, the Netherlands.
Lamers F Lamers Femke F Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Vrije Universiteit Medical Center and GGZ inGeest, Amsterdam, the Netherlands.
Peyrot WJ Peyrot Wouter J WJ Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Vrije Universiteit Medical Center and GGZ inGeest, Amsterdam, the Netherlands.
Baune BT Baune Bernhard T BT Discipline of Psychiatry, University of Adelaide, Adelaide, Australia.
Breen G Breen Gerome G National Institute for Health Research Biomedical Research Centre for Mental Health, King's College London, London, England.
Dehghan A Dehghan Abbas A Department of Epidemiology and Biostatistics, Imperial College London, London, England.
Forstner AJ Forstner Andreas J AJ Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Grabe HJ Grabe Hans J HJ Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
Homuth G Homuth Georg G Interfaculty Institute for Genetics and Functional Genomics, Department of Functional Genomics, University Medicine and Ernst Moritz Arndt University Greifswald, Greifswald, Germany.
Kan C Kan Carol C South London and Maudsley National Health Service Foundation, London, England.
Lewis C Lewis Cathryn C Medical Research Council Social Genetic and Developmental Psychiatry Centre, King's College London, London, England.
Mullins N Mullins Niamh N Medical Research Council Social Genetic and Developmental Psychiatry Centre, King's College London, London, England.
Nauck M Nauck Matthias M Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
Pistis G Pistis Giorgio G Department of Psychiatry, University Hospital of Lausanne, Prilly, Switzerland.
Preisig M Preisig Martin M Department of Psychiatry, University Hospital of Lausanne, Prilly, Switzerland.
Rivera M Rivera Margarita M Department of Biochemistry and Molecular Biology II, Institute of Neurosciences, Center for Biomedical Research, University of Granada, Granada, Spain.
Rietschel M Rietschel Marcella M Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Streit F Streit Fabian F Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Strohmaier J Strohmaier Jana J Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Teumer A Teumer Alexander A Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
Van der Auwera S Van der Auwera Sandra S Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
Wray NR Wray Naomi R NR Queensland Brain Institute, University of Queensland, Brisbane, Australia.
Boomsma DI Boomsma Dorret I DI Department of Biological Psychology, VU University Amsterdam, Amsterdam, the Netherlands.
Penninx BWJH Penninx Brenda W J H BWJH Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Vrije Universiteit Medical Center and GGZ inGeest, Amsterdam, the Netherlands.
CHARGE Inflammation Working Group and the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
INVESTIGATORS
LASTNAME FORENAME INITIALS AFFILIATION
Degan Abbas A
Wray Naomi R. NR
Ripke Stephan S
Mattheisen Manuel M
Trzaskowski Maciej
Adams Mark J . MJ.
Agerbo Esben E
Air Tracy M. TM
Andlauer Till F. M. TFM
Bacanu Silviu-Alin SA
Bækvad-Hansen Marie M
Beekman Aartjan T. F. ATF
Bigdeli Tim B. TB
Binder Elisabeth B. EB
Blackwood Douglas H. R. DHR
Bryois Julien J
Buttenschøn Henriette N. HN
Bybjerg-Grauholm Jonas J
Cai Na N
Castelao Enrique E
Christensen Jane Hvarregaard JH
Clarke Toni-Kim TK
Coleman Jonathan R. I. JRI
Colodro-Conde Lucía L
Couvy-Duchesne Baptiste B
Craddock Nick N
Crawford Gregory E. GE
Davies Gail G
Deary Ian J. IJ
Degenhardt Franziska F
Derks Eske M. EM
Direk Nese N
Eley Thalia C. TC
Escott-Price Valentina V
Farhadi Hassan Kiadeh Farnush F
Finucane Hilary K. HK
Forstner Andreas J. AJ
Frank Josef J
Gaspar Héléna A. HA
Gill Michael M
Goes Fernando S. FS
Gordon Scott D. SD
Hall Lynsey S. LS
Hansen Christine Søholm CS
Hansen Thomas F. TF
Herms Stefan S
Hickie Ian B. IB
Homuth Georg G
Horn Carsten C
Hottenga Jouke-Jan JJ
Ising Marcus M
Jansen Rick R
Jorgenson Eric E
Knowles James A. JA
Kohane Isaac S. IS
Kraft Julia J
Kretzschmar Warren W. WW
Krogh Jesper J
Kutalik Zoltán Z
Li Yihan Y
Lind Penelope A. PA
MacIntyre Donald J. DJ
MacKinnon Dean F. DF
McGrath Patrick P
McGuffin Peter P
Medland Sarah E. SE
Middeldorp Christel M. CM
Mihailov Evelin E
Milaneschi Yuri Y
Mondimore Francis M. FM
Montgomery Grant W. GW
Mostafavi Sara S
Mullins Niamh N
Nauck Matthias M
Ng Bernard B
Nivard Michel G. MG
Nyholt Dale R. DR
O’Reilly Paul F. PF
Oskarsson Hogni H
Owen Michael J. MJ
Painter Jodie N. JN
Pedersen Carsten Bøcker CB
Pedersen Marianne Giørtz MG
Peterson Roseann E. RE
Pettersson Erik E
Peyrot Wouter J. WJ
Pistis Giorgio G
Posthuma Danielle D
Quiroz Jorge A. JA
Qvist Per P
Riley Brien P. BP
Rivera Margarita M
Saeed Mirza Saira S
Schoevers Robert R
Schulte Eva C. EC
Shen Ling L
Shi Jianxin J
Shyn Stanley I. SI
Sigurdsson Engilbert E
Sinnamon Grant C. B. GCB
Smit Johannes H. JH
Smith Daniel J. DJ
Stefansson Hreinn H
Steinberg Stacy S
Streit Fabian F
Strohmaier Jana J
Tansey Katherine E. KE
Teismann Henning H
Teumer Alexander A
Thompson Wesley W
Thomson Pippa A. PA
Thorgeirsson Thorgeir E. TE
Traylor Matthew M
Treutlein Jens J
Trubetskoy Vassily V
Uitterlinden André G. AG
Umbricht Daniel D
Van der Auwera Sandra S
van Hemert Albert M. AM
Viktorin Alexander A
Visscher Peter M. PM
Wang Yunpeng Y
Webb Bradley T. BT
Weinsheimer Shantel Marie SM
Wellmann Jürgen J
Wu Yang Y
Xi Hualin S. HS
Witt Stephanie H. SH
Yang Jian J
Zhang Futao F
Arolt Volker V
Baune Bernhard T. BT
Berger Klaus K
Boomsma Dorret I. DI
Cichon Sven S
Dannlowski Udo U
de Geus E J C EJC
DePaulo J. Raymond JR
Domenici Enrico E
Domschke Katharina K
Esko Tõnu T
Grabe Hans J. HJ
Hamilton Steven P. SP
Hayward Caroline C
Heath Andrew C. AC
Kendler Kenneth S. KS
Kloiber Stefan S
Lewis Glyn G
Li Qingqin S. QS
Lucae Susanne S
Madden Pamela A. F. PAF
Magnusson Patrik K. PK
Martin Nicholas G. NG
McIntosh Andrew M. AM
Metspalu Andres A
Mors Ole O
Mortensen Preben Bo PB
Müller-Myhsok Bertram B
Nordentoft Merete M
Nöthen Markus M. MM
O’Donovan Michael C. MC
Paciga Sara A. SA
Pedersen Nancy L. NL
Penninx Brenda W. J. H. BWJH
Perlis Roy H. RH
Porteous David J. DJ
Potash James B. JB
Preisig Martin M
Rietschel Marcella M
Schaefer Catherine C
Schulze Thomas G. TG
Smoller Jordan W. JW
Stefansson Kari K
Tiemeier Henning H
Uher Rudolf R
Völzke Henry H
Weissman Myrna M. MM
Werge Thomas T
Lewis Cathryn M. CM
Levinson Douglas F. DF
Breen Gerome G
Børglum Anders D. AD
Sullivan Patrick F. PF
JOURNAL
VOLUME: 74
ISSUE: 12
TITLE: JAMA psychiatry
ISOABBREVIATION: JAMA Psychiatry
YEAR: 2017
MONTH: 12
DAY: 01
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN: 2168-6238
ISSNTYPE: Electronic
MEDLINE JOURNAL
MEDLINETA: JAMA Psychiatry
COUNTRY: United States
ISSNLINKING: 2168-622X
NLMUNIQUEID: 101589550
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
COMMENTS AND CORRECTIONS
REFTYPE REFSOURCE REFPMID NOTE
CommentIn JAMA Psychiatry. 2017 Dec 1;74(12):1189-1190 29049499
GRANTS
GRANTID AGENCY COUNTRY
MR/K026992/1 Medical Research Council United Kingdom
R01 MH080403 NIMH NIH HHS United States
U01 MH109532 NIMH NIH HHS United States
S10 OD018164 NIH HHS United States
U01 MH109528 NIMH NIH HHS United States
GENERAL NOTE
KEYWORDS
MESH HEADINGS
DESCRIPTORNAME QUALIFIERNAME
Adult
Body Mass Index
C-Reactive Protein analysis
Craving analysis
Depressive Disorder, Major metabolism
Diagnostic and Statistical Manual of Mental Disorders metabolism
Female metabolism
Genetic Predisposition to Disease metabolism
Genome-Wide Association Study metabolism
Humans metabolism
International Cooperation metabolism
Male metabolism
Obesity psychology
Psychiatric Status Rating Scales psychology
Weight Gain psychology
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
REGISTRYNUMBER NAMEOFSUBSTANCE
9007-41-4 C-Reactive Protein
OTHER ID's